Hormonal diseases focused Diurnal said it achieved positive headline results from proof-of-concept clinical trial for its oral testosterone formulation.
This study evaluated the pharmacokinetics, safety...
Proton system for cancer treatment developer Advanced Oncotherapy launched a £2.7m shar issue to fund verification and validation activity to obtain regulatory approval for its...
Amphion Innovations said it had become a cash shell after the lender of its loan facility sold its holding in medical imaging company Polarean Imaging...
Satellite company Inmarsat said it had presented evidence to a law firm representing some shareholders concerned about its £2.6bn takeover by a consortium comprising Apax,...